about
Discovery of new anticancer agents from higher plantsMultifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.Drug discovery from natural sources.Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agentsAntineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs.Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model.Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.Diverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology.Lophocladines, bioactive alkaloids from the red alga Lophocladia spDesign, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents.Microtubule dynamics as a target in oncology.Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo.Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.Targeted agents in ovarian cancer.An update on the clinical development of drugs to disable tumor vasculature.Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.Early effects of combretastatin A4 phosphate assessed by anatomic and carbogen-based functional magnetic resonance imaging on rat bladder tumors implanted in nude mice.Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside.A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts.Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy.The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells.Synthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analogues.Noninvasive Anatomical and Functional Imaging of Orthotopic Glioblastoma Development and Therapy using Multispectral Optoacoustic Tomography
P2860
Q27006814-8CA32AB3-6CF3-4E58-BCAB-DCC70B149B94Q35488068-6FA5944D-D075-48F7-9442-D96BDD1483DDQ35594873-4966532E-E3CE-484D-A4CB-CBDDA8950C74Q35737288-25FE500F-039C-4CBC-8C78-252C51688B2CQ35855949-DBE8B0DE-8900-46F7-950D-4B605D9513E1Q36413470-660B1251-94C3-42A3-BD51-2F4C1532F078Q36421314-6607F1C3-0273-4C42-AF18-DA9ADBCC6C25Q36613314-066B3B0B-285E-444D-B68D-71C2CE0CC2BDQ37156663-AEDF3924-6625-4301-9ACE-FA1F8746AFF7Q37284843-F314C347-570C-4310-BBAF-A6F0AD8D973EQ37360708-F3E1DA3B-96B3-4635-86BF-BC6481687F9EQ37482734-AB256317-B2B7-4C19-B434-14F34D3F50E2Q37644962-B6F4D919-7403-4FE8-BD83-C203BFF2BB8AQ37795802-0C03345F-2137-4341-82EA-3ED192F26AFAQ38088732-270C67E2-65EC-42E7-A9E8-CAD7FFA128E3Q38088759-0DA12852-C7B5-4FB9-AE9F-9CD293E5F2A7Q38581959-9F653989-A263-4FBA-A2D7-7F54790BBDF1Q38858806-E785BA2D-038E-4635-AC9D-DD8758FB7CB5Q38964866-FF637094-10D0-40E2-B321-37E8F5F3144AQ38976012-EE30FAB5-D607-4BB0-AFE3-762B884A7A42Q39512017-DC79A3EF-AB5F-45CC-A853-F0698FC94990Q41911962-513BF9C7-EA58-4878-9446-D93804BCC832Q49302678-D2330C1F-A252-498A-9CA4-25B8BE9A96D4Q53749320-FC0E65F8-D332-4D47-8D71-C8B20F915DB4Q58788483-8358354A-E90E-473F-B8E4-A3C7368A58FC
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Combretastatin A4 phosphate.
@ast
Combretastatin A4 phosphate.
@en
type
label
Combretastatin A4 phosphate.
@ast
Combretastatin A4 phosphate.
@en
prefLabel
Combretastatin A4 phosphate.
@ast
Combretastatin A4 phosphate.
@en
P1433
P1476
Combretastatin A4 phosphate.
@en
P2093
Catharine M L West
P304
P356
10.1097/00001813-200403000-00001
P577
2004-03-01T00:00:00Z